论文部分内容阅读
本文观察利格列汀对早期2型糖尿病肾病患者尿蛋白排泄率、纤维化因子以及炎症因子的影响。报告如下。1资料与方法1.1临床资料根据1999年世界卫生组织糖尿病诊断标准及NKF/KDOQI糖尿病肾病诊断标准,选择2016年1月~2017年1月在我院内分泌科治疗的2型糖尿病肾病患者98例,尿蛋白排泄率(UACR)为30~300mg/g;男50例,女48例;平均年龄(52.68±10.35)岁。按照随机数字表法将其分
This article investigates the effects of linagliptin on urinary protein excretion, fibrosis and inflammatory factors in patients with early type 2 diabetic nephropathy. The report is as follows. 1 Materials and Methods 1.1 Clinical data According to the 1999 WHO diagnostic criteria for diabetes and NKF / KDOQI diabetic nephropathy diagnostic criteria, select January 2016 ~ January 2017 in our hospital endocrine treatment of type 2 diabetic nephropathy in 98 cases, Urinary protein excretion rate (UACR) of 30 ~ 300mg / g; 50 males and 48 females; mean age (52.68 ± 10.35) years old. According to the random number table method will be divided